Location History:
- Plainsboro, NJ (US) (2001)
- Wallingford, CT (US) (2018 - 2021)
- Middletown, CT (US) (2004 - 2022)
- New Hope, PA (US) (2021 - 2024)
Company Filing History:
34 out of 3,685 
7 out of 42 
4 out of 8 Years Active: 2001-2025
Areas of Expertise:
Title: Innovations in Biopharmaceuticals: The Remarkable Contributions of Alicia Regueiro-Ren
Introduction: Alicia Regueiro-Ren, based in Middletown, CT, has made significant strides in the biopharmaceutical sector with an impressive portfolio of 38 patents. These innovations primarily focus on unique compounds that serve as therapeutic agents, highlighting her commitment to advancing medical science.
Latest Patents: Among her latest patents, Alicia has developed "Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors." This work relates to compounds that can inhibit Gal-3, encompassing pharmaceutically acceptable salts and methods for their use. Another noteworthy patent is for "Triterpenoids with HIV maturation inhibitory activity," which describes compounds with unique antiviral properties designed to combat HIV and AIDS.
Career Highlights: Alicia's career includes influential roles at prominent pharmaceutical companies such as Bristol-Myers Squibb Company and ViiV Healthcare UK Limited. Her work at these organizations has been pivotal in not only advancing drug development but also improving patient outcomes.
Collaborations: Throughout her career, Alicia has collaborated with esteemed professionals, including Nicholas A. Meanwell and Jacob Swidorski. These partnerships have facilitated the sharing of ideas and expertise, contributing to the successful development of her innovative compounds.
Conclusion: Alicia Regueiro-Ren's contributions through her patents reflect her dedication to addressing critical health challenges. Her innovative work continues to pave the way for new therapeutic options in the fields of HIV treatment and beyond, solidifying her status as a leading inventor in biopharmaceutical innovation.